Hepatology: University of Texas, MD Anderson

Total Score People Score Events Score
58 51 24
Date Event Presentation Speakers
October 24, 2015 19th International Meeting of the European Society of Gynaecological Oncology (ESGO 2015) Parallel: Challenges in the Management of Cervical Cancer Pedro T. Ramirez
Fellows’ Seminar: Tips and tricks in pelvic laparoscopic surgery & ESGO Quiz Pedro T. Ramirez
April 11, 2014 6th Annual Asian Oncology Summit and 10th Annual Conference of the Organisation for Oncology and Translational Research (OOTR) 6th Annual Asian Oncology Summit and 10th Annual Conference of the Organisation for Oncology and Translational Research (OOTR) Rakesh Kumar
January 30, 2014 Genitourinary Cancers Symposium A Decade in Review: Prostate Cancer Deborah Kuban
October 28, 2013 Tumor Immunology and Immunotherapy TNFalpha and TLR3/4 induced necrosis pathway Xiaodong Wang
October 27, 2013 Nature - CNIO Cancer Symposium: Frontiers in Tumour Heterogeneity and Plasticity Using Neurofibromatosis to model Cancer: therapeutic insights Luis F Parada
May 31, 2013 ASCO Annual Meeting 2013 Management of Chronic Lymphocytic Leukemia (M10) William G. Wierda
Education Sessions Anas Younes
Education Sessions John de Groot
Special Session Razelle Kurzrock, Gabriel N Hortobagyi
Education Sessions Robert L. Coleman
Educations Sessions Jeffrey E Gershenwald, Stanley Hamilton
April 6, 2013 AACR Annual Meetings Drug Discovery in Industry, Academia, and Government: What Is the Track Record? Michael A. White
Clinical Trial Design in the Genomic Era Co-Chairpersons: Donald A. Berry, The University of Texas MD Anderson Cancer Center, Houston, TX, and George W. Sledge, Jr., Stanford University School of Medicine, Stanford, CA Donald Berry
Rational Combination Therapies in Cancer Chairperson: Gordon B. Mills, The University of Texas MD Anderson Cancer Center, Houston, TX Gordon Mills
Bridging the Gap Between Clinical Research and Laboratory Investigation: Utilizing Presurgical Clinical Trials to Investigate Anti-CTLA-4 Immunotherapy Padmanee Sharma, The University of Texas MD Anderson Cancer Center, Houston, TX Padmanee Sharma
Whole Body Metabolism and Cancer Chairperson: Philipp E. Scherer, UT Southwestern Medical Center, Dallas, TX Philipp Scherer
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY George A. Calin
Identifying Novel Redox Signaling Pathways for Cancer Chemoprevention: From Fly to the Mouse Garth Powis, The University of Texas MD Anderson Cancer Center, Houston, TX Garth Powis
PAK Family of Kinases in Human Cancer: Past, Present, and Future Rakesh Kumar, George Washington University, Washington, DC Rakesh Kumar
December 13, 2011 New Horizons in Cancer Research: Biology to Prevention to Therapy Genomic alterations in gingivobuccal cancer: Results from whole-exome resequencing Sadhan Majumder
Prostaglandin E2 promotes intestinal tumor growth via DNA methylation Raymond N DuBois
Plenary Session 5 | Cancer Prevention and Chemoprevention Raymond N DuBois
Day in Review Raymond N DuBois
Session 4 | Molecular Epidemiology of Cancer: Towards Personalized Risk Assessment, Prevention, and Therapy Xifeng Wu
November 15, 2011 Cosa 38th Annual Scientific Meeting Management of Ta and T1 bladder cancer Michael Wallace
July 30, 2011 MD Anderson Physicians Network Symposium Changing Paradigms in Cancer Treatment and Patient Management Non-Small Cell Lung Cancer | Combined Modality Therapy for Patients with Stage II/III Disease Scott M Lippman
Making Sense of Multigene Assays in Practice Ana Gonzalez-Angulo
HER-2 Directed Therapies: Adjuvant or Neoadjuvant? Ana Gonzalez-Angulo
Challenging Case Presentations and Interactive Audience Participation Deborah Kuban
Dose Escalation and Stereotactic Therapy in the Management of Pancreatic Cancer Sunil Krishnan
Active Surveillance vs. Treatment in the Management of Prostate Cancer Deborah Kuban
Molecular Markers Guiding Diagnosis and Optimizing Management of Leukemias Stefan Faderl
Emerging Paradigms in the Management of Myeloproliferative Disorders Stefan Faderl
New Therapeutic Targets in Lymphoma | The B-cell Receptor, CD-30 Fredrick B Hagemeister
PET Scan in Lymphoma: Which Histologies? When? Can it Guide Treatment? Fredrick B Hagemeister
Advances in RT: IMRT, Short Course and Selective Omission of RT Sunil Krishnan
June 30, 2011 2011 AHPBA Americas Post Graduate Course Session 2 | Future Perspectives on Treatment Sequencing for Hepatocellular Carcinoma Steven A Curley
November 7, 2010 Ninth Annual International Conference on Frontiers in Cancer Prevention Research Professional Advancement Session Margaret R. Spitz
Proximity of personalized risk and predictive markers to the clinic Scott M Lippman
Plenary Session 1: Personalized Prevention Scott M Lippman
Efficient designs for lung cancer prevention trials: Lessons learned and moving forward J. Jack Lee
Report on AACR-NCI Think Tank: Charting the Future of Cancer Prevention Raymond N DuBois
June 4, 2010 From Chronic Inflammation to Cancer Chronic inflammation and gene polymorphism C. Richard Boland
January 22, 2010 2010 Gastrointestinal Cancers Symposium Surgical Oncologist Roderich Schwarz
Is There Resistance to Anti-angiogenic Agents? Lee M Ellis
GI Cancer Stem Cells: Bench to Bedside Jaffer A. Ajani
Medical Oncologist Gauri Varadhachary
Chemoprevention: Who Can Benefit? Robert S Bresalier
Primer in Cancer Genetics Miguel Rodriguez-Bigas
General Session IX: Cancers of the Colon and Rectum: Multidisciplinary Treatment Cathy Eng
Angiogenesis Inhibition and Its Impact on Future Adjuvant Studies and Advanced Disease Lee M Ellis
Medical Oncologists Cathy Eng
Case Presentation 2: Locally Advanced (Radiotherapy vs. Chemotherapy) Gauri Varadhachary
Panel Discussion With Interactive Q/A Sushovan Guha
A Novel Small Molecule Inhibitor of Protein Kinase D Blocks Pancreatic Cancer Growth In Vivo Sushovan Guha
Prognostic Factors of Rectal and Anal Cancer Outcomes Prajnan Das
Panel Discussion With Interactive Q/A Ju-Seog Lee
Molecular Biology: East and West Ju-Seog Lee
September 23, 2009 TRACK 1: Optimizing Clinical Trials : Third Annual Adaptive Clinical Trial Designs Personalized Medicine: Using Biomarker Signatures to Predict Response to New Therapies J. Kyle Wathen
June 8, 2009 Genotyping Tools Rare Functional SNPs and the Genetic Architecture of Complex Diseases Ivan Gorlov
June 8, 2009 RNAi for Functional Screens Towards Functional Annotation of the Cancer Genome Michael A. White
March 2, 2008 MOLECULAR MECHANISMS IN LYMPHATIC FUNCTION & DISEASE The regulation of the real lymphatic function - lymph transport David Zawieja
February 10, 2008 GRC - Plasminogen Activation & Extracellular Proteolysis PCSK9, a secreted protease with a non-protease function Jay Horton
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 2: Anti-Cancer/Tumors Drug Discovery & Development and Current Status of the Innovative Therapeutics (Part I) (13:30-17:30) Dr. Xiaodong Cheng
session 2: Identification of Selective Anti-pancreatic Cancer Inhibitors Using Synthetic Lethal Chemical Screening (14:30-14:50) Dr. Xiaodong Cheng
Session 11: Anti-Infectious Drug Discovery & Development (II) (09:00-12:20) Stanley J. Watowich
Session 11: Global Grid-computing Initiative to Discover Novel Dengue and Hepatitis C Antivirals (09:40-10:00) Stanley J. Watowich
October 17, 2007 Exploring Next Generation Sequencing: Applications and Case Studies (Oct 17-18) Genome Resequencing for Mutation Screening (13:30-18:30) George A. Calin
Genome Resequencing for Mutation Screening: Toward a Non-Coding RNA Revolution in the Cancer Society (14:50-15:20) George A. Calin
October 16, 2007 Inaugural HDAC inhibitors: Meeting the Challenges of Chemical Development of HDAC Inhibitors Oct (16 -17) MOLECULAR MODE-OF-ACTION AND BIOMARKER STRATEGIES FOR CLINICAL DEVELOPMENT(11:10-16:30) Madeleine Duvic
MOLECULAR MODE-OF-ACTION AND BIOMARKER STRATEGIES FOR CLINICAL DEVELOPMENT: Panel Discussion- Are HDAC Inhibitors Proving Their Worth in the Clinic? (14:25-15:25) Madeleine Duvic
July 7, 2007 Protein Kinases and Protein Phosphorylation Ubiquitin-mediated activation of TAK1 and IKK Zhijian James Chen
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.